# First Trust NYSE Arca Biotechnology UCITS ETF Accum A USD (FBT) **Page:** https://fundology.uk/fund/fbt · ISIN IE00BL0L0H60 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, FBT (First Trust NYSE Arca Biotechnology UCITS ETF Accum A USD, ISIN IE00BL0L0H60) closed at £24.91 on the London Stock Exchange. Its ongoing charge is 0.60% a year (about £60 on £10,000). Over the five years to 13/11/2026 its total return was +56.0%, or +21.8% after UK CPIH inflation. ## Summary First Trust Global Funds ICAV - First Trust NYSE Arca Biotechnology UCITS ETF Accum A USD is an exchange-traded fund (ETF) from First Trust, launched in 2020. It tracks the NYSE Arca Biotechnology (TR). You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.6% a year — about £60 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£24.91** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | FBT | | ISIN | IE00BL0L0H60 | | Also listed as | FBTU (London Stock Exchange, US dollars) | | Category | Healthcare | | Type | ETF | | Provider | First Trust | | Tracks | NYSE Arca Biotechnology (TR) | | Income | Accumulating | | Ongoing charge | 0.60% a year (£60 per £10,000) | | Fund size | £13.8m | | Launched | 2020 | | Domicile | Ireland | | UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 27/05/2020 | ## Past returns (periods to 13/11/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +34.95% | +30.17% | income reinvested | | 3 years | +88.58% | +70.38% | income reinvested | | 5 years | +55.99% | +21.76% | income reinvested | Returns: as reported (delayed data). Inflation: UK CPIH, latest month published. ## Calendar-year returns Calendar-year returns of First Trust Global Funds ICAV - First Trust NYSE Arca Biotechnology UCITS ETF Accum A USD in pounds (price, with income reinvested in the fund): 2022 +5.3%, 2023 −1.8%, 2024 +8.6%, 2025 +13.7%; 2026 to 13/11/2026 +32.2%. Returns of First Trust Global Funds ICAV - First Trust NYSE Arca Biotechnology UCITS ETF Accum A USD in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +48.2%; to 30/09/2025: +9.3%; to 30/09/2024: +6.4%; to 30/09/2023: −0.7%; to 30/09/2022: −0.2%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | +5.3% | -3.6% | Price | | 2023 | -1.8% | -5.7% | Price | | 2024 | +8.6% | +4.9% | Price | | 2025 | +13.7% | +9.8% | Price | | 2026 to 13/11/2026 | +32.2% | +28.0% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 19.91% | -11.16% | | 3 years | 18.44% | -23.09% | | 5 years | 18.21% | -23.09% | ## Largest fall Volatility of First Trust Global Funds ICAV - First Trust NYSE Arca Biotechnology UCITS ETF Accum A USD in pounds, annualised from weekly returns to 13/11/2026: 19.9% over 1 year, 18.4% over 3 years, 18.2% over 5 years. Largest fall in the price of First Trust Global Funds ICAV - First Trust NYSE Arca Biotechnology UCITS ETF Accum A USD since November 2021, in pounds: −23.1% from 31/01/2025 to 11/04/2025. The lowest 12-month return of First Trust Global Funds ICAV - First Trust NYSE Arca Biotechnology UCITS ETF Accum A USD in pounds (price, with income reinvested in the fund) since January 2021 was −18.3% (12 months to 28/01/2022); the highest was +59.2% (12 months to 03/07/2026). On 13/11/2026 the price of First Trust Global Funds ICAV - First Trust NYSE Arca Biotechnology UCITS ETF Accum A USD was 2.8% below its highest weekly close since November 2021 (30/10/2026), in pounds. ## Charges compared with similar funds Ongoing charge of First Trust Global Funds ICAV - First Trust NYSE Arca Biotechnology UCITS ETF Accum A USD 0.60% a year. Compared on 14/11/2026, 2 of the 28 other healthcare funds charge more, 0 the same and 26 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.60%** per year - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## Questions people ask **What is the ongoing charge of FBT?** The ongoing charge of FBT is 0.60% a year — about £60 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of First Trust Global Funds ICAV - First Trust NYSE Arca Biotechnology UCITS ETF Accum A USD 0.60% a year. Compared on 14/11/2026, 2 of the 28 other healthcare funds charge more, 0 the same and 26 less (share classes counted once). **What does FBT track?** FBT tracks the NYSE Arca Biotechnology (TR). **Is FBT accumulating or distributing?** FBT is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of FBT?** The ISIN of FBT is IE00BL0L0H60. An ISIN identifies one exact share class of a fund; FBT is its ticker on the London Stock Exchange. The same share class is also listed as FBTU (London Stock Exchange, US dollars). **What were FBT’s returns in each of the last five years?** Calendar-year returns of FBT in pounds (price, with income reinvested in the fund): 2022 +5.3%, 2023 −1.8%, 2024 +8.6%, 2025 +13.7%; 2026 to 13/11/2026 +32.2%. Past performance is not a guide to future returns. **How has FBT done after inflation?** Over the five years to 13/11/2026 FBT’s total return was +56.0%, or +21.8% after UK CPIH inflation. Past performance is not a guide to future returns. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.